Clinical Trial Update: Beta-2 Microglobulin and Serum Cytokines x HAART

View source ↗

Summary

This clinical trial update reports results from a completed study examining Beta-2 microglobulin and serum cytokines in HIV patients receiving HAART.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: UPECLIN HC FM Botucatu Unesp | Conditions: HIV Patients | Status: COMPLETED